Cardiology: Treatment of Systolic Heart Failure in the Elderly: An Evidence-Based Review

2010 ◽  
Vol 44 (10) ◽  
pp. 1604-1614 ◽  
Author(s):  
Sally A Arif ◽  
Karl A Mergenhagen ◽  
Roberto O Diaz Del Carpio ◽  
Christopher Ho
Keyword(s):  
Heart Failure ◽  
Systolic Heart Failure ◽  
The Elderly ◽  
Evidence Based

Systolic heart failure in the elderly: optimizing medical management

2011 ◽  
Vol 17 (4-5) ◽  
pp. 563-571 ◽  
Author(s):  
Jonathan P. Man ◽  
Bodh I. Jugdutt
Keyword(s):  
Heart Failure ◽  
Medical Management ◽  
Systolic Heart Failure ◽  
The Elderly

scholarly journals Exercise Training for Heart Failure Patients with and without Systolic Dysfunction: An Evidence-Based Analysis of How Patients Benefit

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Neil Smart
Keyword(s):  
Heart Failure ◽  
Exercise Training ◽  
Systolic Function ◽  
Controlled Trial ◽  
Systolic Dysfunction ◽  
Systolic Heart Failure ◽  
Evidence Based ◽  
Heart Failure Patients ◽  
Age Related ◽  
Clinical Benefits

Significant benefits can be derived by heart failure patients from exercise training. This paper provides an evidence-based assessment of expected clinical benefits of exercise training for heart failure patients. Meta-analyses and randomized, controlled trials of exercise training in heart failure patients were reviewed from a search of PubMed, Cochrane Controlled Trial Registry (CCTR), CINAHL, and EMBASE. Exercise training improves functional capacity, quality of life, hospitalization, and systolic and diastolic function in heart failure patients. Heart failure patients with preserved systolic function (HFnEF) participating in exercise training studies are more likely to be women and are 5–7 years older than their systolic heart failure (CHF) counterparts. All patients exhibit low functional capacities, although in HFnEF patients this may be age related, therefore subtle differences in exercise prescriptions are required. Published works report that exercise training is beneficial for heart failure patients with and without systolic dysfunction.

A single centre study assessing the effectiveness of active monitoring, using telemedicine, in preventing heart failure admissions and death in a primary care population with systolic heart failure.

2020 ◽  
Author(s):  
Nicola Bowers ◽  
Ben Lodge ◽  
Charlie Clifford ◽  
Ricardo Pio Monti ◽  
Marc Phippen ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Left Ventricular Systolic Dysfunction ◽  
Systolic Heart Failure ◽  
Left Ventricular ◽  
Active Group ◽  
Control Group ◽  
P Value ◽  
Evidence Based ◽  
Significant Difference

Abstract BackgroundPatients with systolic heart failure are at high risk of admission to hospital and death. This can be reduced by ensuring that they are receiving all evidence-based heart failure medications and by detecting early signs of deterioration in their condition.MethodsWe recruited 209 primary care patients with echocardiographically proven left ventricular systolic dysfunction (ejection fraction < 40%). 84 patients consented to be actively monitored by the heart failure team using telemedicine. 125 patients consented to receiving usual care but allowing access to their medical records. The primary end-point was cardiovascular death or admission to hospital for heart failure at 1 year. Secondary end-points included the prescription of evidence-based heart failure medications and patient satisfaction at the end of the study.ResultsThere was no difference in the mortality rate between the groups (6.02% in the active group and 5.56% in control). There was a significant difference in hospital admission (10.84% in the active group and 1.59% in control; p-value of 0.0078). At the end of the study, in the active group v control group, 92% v 52% of patients were on a beta-blocker, 92% v 48% on ACE-I/ARB, and 60% v 30% on an MRA. There were no differences in the final doses achieved.ConclusionsActive telemonitoring in an elderly population with systolic heart failure did not reduce cardiovascular mortality or admission to hospital for heart failure over the 1 year of the study. It did result in more patients receiving evidence based heart failure medications.Trial registrationThis trial received ethical approval from the Health Research Authority London-City Road and Hampstead Research Ethics Committee (REC Reference: 16/L0/0070, IRAS project ID: 173818). The ClinicalTrials.gov Identifier number is: NCT04371731. This trial was retrospectively registered on 30/4/2020 and this study adheres to CONSORT guidelines

The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice

2016 ◽  
Vol 21 (6) ◽  
pp. 675-697 ◽  
Author(s):  
Ken Lee Chin ◽  
Marina Skiba ◽  
Andrew Tonkin ◽  
Christopher M. Reid ◽  
Danny Liew ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systematic Review ◽  
Systolic Heart Failure ◽  
Evidence Based ◽  
Treatment Gap ◽  
Chronic Systolic Heart Failure
Sign in / Sign up

Export Citation Format

Share Document